Vaccinex Inc (VCNX)

Dec 19, 2024

Vaccinex Stock to Be Delisted From Nasdaq - Marketscreener.com

Dec 19, 2024

Dec 19, 2024

Vaccinex (OTC:VCNX) Stock Quotes, Forecast and News Summary - Benzinga

Dec 19, 2024

Dec 19, 2024

Vaccinex Faces Delisting from Nasdaq, Details Plans for OTC Quotation - Defense World

Dec 19, 2024

Dec 18, 2024

Vaccinex to be delisted from Nasdaq over equity shortfall By Investing.com - Investing.com South Africa

Dec 18, 2024

Dec 17, 2024

Vaccinex to be delisted from Nasdaq over equity shortfall - Investing.com India

Dec 17, 2024

Dec 17, 2024

Vaccinex Shares Tumble 63% On Nasdaq Delisting - MarketWatch

Dec 17, 2024

Dec 17, 2024

Vaccinex Faces Nasdaq Delisting Amid Financial Struggles; Shares Drop 62% - Yahoo Finance

Dec 17, 2024

Dec 17, 2024

Vaccinex stock plunges to 52-week low at $1.36 amid market challenges - Investing.com

Dec 17, 2024

Dec 17, 2024

Vaccinex Announces Receipt of Delisting Notification from Nasdaq - The Manila Times

Dec 17, 2024

Dec 17, 2024

Vaccinex Faces Nasdaq Delisting After Failing Minimum Equity Requirements, Moves to OTC Markets - StockTitan

Dec 17, 2024

Dec 04, 2024

Vaccinex (NASDAQ:VCNX) Trading 11.1% Higher – Time to Buy? - Defense World

Dec 04, 2024

Nov 18, 2024

Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 18, 2024

Nov 18, 2024

Vaccinex Reports Promising Alzheimer's Drug Data, Raises $8.35M Amid Financial Challenges | VCNX Stock News - StockTitan

Nov 18, 2024

Nov 15, 2024

Vaccinex secures $2.15 million in private placement - Investing.com

Nov 15, 2024

Nov 15, 2024

Vaccinex Inc (VCNX) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 15, 2024

Vaccinex secures $2.15 million in private placement By Investing.com - Investing.com UK

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires Shares in Vaccinex Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Vaccinex, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Nov 08, 2024

Latest Company News - Investing.com

Nov 08, 2024

Nov 08, 2024

Vaccinex inks multiple antibody discovery deals using ActivMAb By Investing.com - Investing.com Canada

Nov 08, 2024

Nov 07, 2024

Vaccinex inks multiple antibody discovery deals using ActivMAb - Investing.com India

Nov 07, 2024

Nov 07, 2024

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

Vaccinex Lands Major Pharma Deals: Amgen, Merck Partner on Breakthrough Antibody Tech | VCNX Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

Vaccinex Reports Improved Immunity Correlating with - GlobeNewswire

Nov 06, 2024

Nov 05, 2024

VCNXVaccinex, Inc. Latest Stock News & Market Updates - StockTitan

Nov 05, 2024

Nov 05, 2024

Vaccinex's Pepinemab Breakthrough: New Data Shows Enhanced Cancer Immunotherapy Success | VCNX Stock News - StockTitan

Nov 05, 2024

Nov 01, 2024

Vaccinex reports progress in Alzheimer's treatment study By Investing.com - Investing.com Canada

Nov 01, 2024

Nov 01, 2024

Vaccinex reports progress in Alzheimer's treatment study - Investing.com India

Nov 01, 2024

Oct 31, 2024

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 - GlobeNewswire

Oct 31, 2024

Oct 31, 2024

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain - Nasdaq

Oct 31, 2024

Oct 28, 2024

Vaccinex stock tanks 40% despite positive Alzheimer’s study update - MSN

Oct 28, 2024

Oct 25, 2024

Vaccinex Stock Spikes On 'Promising' Data On Alzheimer’s Drug Study: Retail Sentiment Brightens - Barchart

Oct 25, 2024

Oct 24, 2024

Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024 - GlobeNewswire

Oct 24, 2024

Oct 20, 2024

Micron Technology (MU-Q) QuotePress Release - The Globe and Mail

Oct 20, 2024

Oct 15, 2024

Orange Juice (OJX25) Quote - The Globe and Mail

Oct 15, 2024

Oct 14, 2024

Antibody Library Technology Market Report to 2032 -AnaptysBio Inc, MorphoSys AG, XOMA Corporation, Abzena Plc, AvantGen – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024

Oct 09, 2024

Vaccinex faces potential Nasdaq delisting over equity shortfall - Investing.com India

Oct 09, 2024

Oct 09, 2024

BTIG Research’s latest rating for VCNX stock - Knox Daily

Oct 09, 2024

Oct 09, 2024

Vaccinex faces potential Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada

Oct 09, 2024

Oct 09, 2024

Company’s Banking Shares: Up -90.42% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle

Oct 09, 2024

Oct 09, 2024

Post-Trade Analysis: Vaccinex Inc (VCNX) Slides -27.92, Closing at 1.73 - The Dwinnex

Oct 09, 2024

Oct 02, 2024

Vaccinex stock hits 52-week low at $2.98 amid market challenges - Investing.com

Oct 02, 2024

Sep 25, 2024

Vaccinex stock hits 52-week low at $4.17 amid sharp annual decline - Investing.com Canada

Sep 25, 2024

Sep 25, 2024

VSME’s price-to-free cash flow ratio: What it means for investors - US Post News

Sep 25, 2024

Sep 25, 2024

Short Interest in Victory Square Technologies Inc. (OTCMKTS:VSQTF) Declines By 79.4% - Defense World

Sep 25, 2024

Sep 25, 2024

Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Purchased by Victory Capital Management Inc. - Defense World

Sep 25, 2024

Sep 24, 2024

WUXI BIO Buys back ~3.32M Shrs for ~$42.55M Ytd - AASTOCKS.com

Sep 24, 2024